Molecule Details
| InChIKey | AQGNHMOJWBZFQQ-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.13 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB19676 |
|---|---|
| Drug Name | Laduviglusib |
| CAS Number | 252917-06-9 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Laduviglusib is a small molecule drug. Laduviglusib has a monoisotopic molecular weight of 464.1 Da. |
Categories: Glycogen Synthase Kinase 3, antagonists & inhibitors
Cross-references: BindingDB: 50325983 ChEBI: 91091 CHEMBL412142 PDB: 65C ZINC: ZINC000029053046